After working hands-on with AI for 90 days, partner Trey Cox shared with Corporate Counsel the three things he knows, three things he thinks, and three things he predicts about the role of AI in litigation — and what that means for clients and lawyers alike.
Partner Rosemary Spaziani spoke with Bloomberg Law (subscription required) about President Trump’s landmark legislation that seeks to streamline an assortment of state-level regulations of stablecoins, tasking a federal committee with screening and recertifying each state regime to align with the statute itself.
Discussing whether the process will result in rubber stamps or bottlenecks, Ro said: “If 40 states all sign on to what the federal government does, those are going to be pretty simple rubber stamps — they’re going to adopt a model act and incorporate it into their laws.” She added, “The ones that deviate are probably going to be a bit of a bottleneck.”
Gibson Dunn is highly recommended in World Intellectual Property Review’s Global Trade Secrets 2025 rankings. The rankings provide a global directory of the “preeminent law firms and lawyers who advise major clients on the most significant global trade secrets matters.”
The publication describes Gibson Dunn as “among the top firms for complex, critical trade secrets matters.”
Gibson Dunn has advised Mubadala Capital with the hybrid preferred equity financing for its take-private of CI Financial Corp., one of North America’s leading diversified asset and wealth management companies. The transaction has an implied enterprise value of approximately C$12.1 billion and marks a significant milestone in Mubadala Capital’s expansion into private wealth management.
Our New York corporate team was led by partner Michael Saliba and included associates James Sullivan, Lily Paulson Stephens, Melody Karmana, and Mackenzie Alpert.
Writing in the International AI in Financial Services Review 2025/26, published by Beaumont Capital Markets, of counsel Sameera Kimatrai and associate Aliya Padhani examine the growing role of AI in financial services and the pressing need for responsible governance.
In their article, “Deploying AI in Financial Institutions – Legal and Governance Best Practices,” they explore how AI is rapidly moving from experimentation to mainstream deployment in jurisdictions such as the United Arab Emirates, and why boards and senior leaders should take active responsibility for ensuring its use is ethical, transparent, and well-governed. They also highlight the importance of embedding human oversight and core principles from the outset to ensure AI is harnessed responsibly.
Partner Sydney Scott has been recognized by the Houston Business Journal in its list of 2025 Women Who Mean Business. The list honors lawyers who have demonstrated exceptional leadership and made a significant impact on Houston’s business community.
Partner Harrison Tucker recently spoke to Barron’s about an increase in IPO activity, particularly among crypto-related firms looking to capitalize on the strong market and growing investor appetite for exposure to digital assets.
As Harrison told the publication: “The IPO market has been fairly open for the past three months, and crypto companies in particular have benefited from that… Investors want access to this nascent industry.”
Partner Julia Lapitskaya spoke to Agenda about the challenges companies face in balancing the need to disclose security practices to satisfy investors with the responsibility to protect their employees.
Julia emphasized that while disclosures must be comprehensive, companies should avoid presenting security measures in ways that could compromise their effectiveness. “Companies who do talk about being committed to the safety, health and well-being of their employees are talking [about]… protecting their team members everywhere they operate and providing them with specific crisis management security and safety trainings.”
Gibson Dunn is representing RTW Investments, LP in its acquisition from Aquestive Therapeutics, Inc of a synthetic royalty interest in Anaphylm™ (epinephrine) Sublingual Film, and in its acquisition of Aquestive common stock as the lead investor in the company’s $85 million underwritten offering.
Our corporate team is led by partner Ryan Murr and includes associates Evan Shepherd and Catie Sakurai. Partner Ryan Kim and associate Kali Jelen are advising on financing. Partner Pamela Lawrence Endreny is advising on tax.
Gibson Dunn has once again been included in The American Lawyer’s A-List ranking of the country’s premier law firms.
Widely considered the publication’s most prestigious ranking, the 2025 A-List recognizes the country’s top 20 law firms based on a combination of factors, both financial and cultural: revenue per lawyer, pro bono commitment, associate satisfaction, racial diversity, and gender diversity (the percentage of equity partners who are women), with revenue per lawyer and pro bono given double weight.
Partner Ryan Murr recently shared his insights about the rise of royalty financing deals in the market with Scrip (registration required), a Citeline Commercial publication.
Ryan is Co-Chair of our Life Sciences Practice Group.
Partner Richard Birns has been named a Notable M&A Dealmaker 2025 by Crain’s New York Business. The list recognizes individuals shaping the M&A landscape in New York.
Richard is Co-Chair of our Private Equity Practice Group and Chair of our Sports Law Practice Group.
Partner Krista Hanvey has been named to Bloomberg Law’s “They’ve Got Next: The 40 Under 40” list, which recognizes lawyers who “excel and innovate in their work for clients, in their leadership in their organizations, and in their service to their communities.”
In her interview with the publication, Krista reflected on recent wins, career-defining lessons, and her approach to building strong client relationships. She shared that building long-term partnerships comes from deeply understanding a client’s business strategy and challenges and becoming part of their team. “While technical expertise is important, being able to frame an issue for different audiences to explain legal considerations in a digestible format and to come up with creative solutions that can practically be implemented — within budget and time constraints — can make you instrumental for your clients. I view success as being the ‘go to’ lawyer for my clients over many years.”
Krista is Co-Chair of our Employee Benefits and Executive Compensation Practice Group and Co-Partner in Charge of our Dallas office.
Gibson Dunn has secured first place as lead counsel in Debtwire’s Restructuring Advisory Mandates Report – Europe for the first half of 2025, with seven mandates.
Gibson Dunn is advising Arrowhead Pharmaceuticals on an asset purchase agreement between Sanofi and Visirna Therapeutics, a majority-owned subsidiary of Arrowhead. Under the terms, Sanofi will acquire rights to develop and commercialize investigational plozasiran in Greater China.
Led by partner Karen Spindler, our corporate team includes partner Jin Hee Kim and associates Paul Rafla and Sonari Chidi. Partners Pamela Lawrence Endreny and Benjamin Rapp and associate Ryan Rott are advising on tax; partner Cassandra Gaedt-Sheckter and associate Courtney Wang are advising on data privacy; and partner John Partridge and of counsel Ning Ning are advising on compliance.
Gibson Dunn advised Asterion Industrial Partners, an independent investment management firm with an experienced team focusing on European infrastructure, on the sale of a 28% stake in Italian renewables company Sorgenia.
The transaction forms part of a strategic reorganisation that also includes the entry of Sixth Street as a new shareholder in the company, now valued at over €4 billion. The sale follows the successful completion of a transformation process launched in 2020 by Asterion, in partnership with F2i, Italy’s largest independent infrastructure fund manager.
Our team was led by partner Wim De Vlieger and included associates Osvaldo Galeano and Romain Tourenne and staff attorney Carmen Heredia.
Gibson Dunn is advising Aris Water Solutions (NYSE: ARIS) on its sale to Western Midstream Partners (NYSE: WES) for approximately $2 billion.
Our corporate deal team is led by partners Hillary Holmes and Tull Florey, and includes associates Jonathan Sapp, Adri Langemeier, Mariana Lozano, and Muriel Hague.
Senior counsel Gregory Nelson and associate Nathan Sauers are advising on tax; partner Sean Feller and associate John Curran are advising on compensation; partner Sophia Hansell and associate Alexander Merritt are advising on antitrust; partner Adam Whitehouse is advising on oil and gas; and of counsel Robbie Hopkins and associates Malakeh Hijazi and Allan Jeanjaquet are advising on securities.
Gibson Dunn is advising Daikin Applied on its acquisition of DDC Solutions, a San Diego-based developer of ultra-high-density cooling cabinets and management software for data centers.
Our corporate team is led by partner Stephen Olson and associate Jonathan Sapp and includes associates Gerald Kimani, Caroline Bakewell, and Andrew Watson. Partner Michael Cannon and associate Yara Mansour are advising on tax; partner Gina Hancock and associate Kayoko Fong are advising on benefits; and counsel Andrew Cline is advising on antitrust.
Partner Jake M. Shields spoke to Private Funds CFO to discuss recent amendments to the U.S. state of Massachusetts’ False Claims Act and their impact on private equity GPs with portfolio companies doing business in the state or with local governments.
The changes require sponsors to report any identified violations within 60 days to the state or relevant localities or face financial penalties and damages.
Jake explained that while GPs can already potentially be held liable under federal law in certain situations such as where they are found to have actively or even passively “ratified” unlawful conduct by portfolio companies, the Massachusetts update goes further by implementing an affirmative duty to report known misconduct. As he told the publication, “They take the ratification theory and turbocharge it.”
Gibson Dunn is advising Alcon on its $1.5 billion acquisition of STAAR Surgical Company.
Our corporate team includes partners Branden Berns, Evan D’Amico, and George Sampas, along with associate Jonathan Sapp.